Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

Exclusion Criteria

• •1. Systemic diseases that may cause mesangial IgA deposition.
• •2. Patients who have undergone a kidney transplant.
• •3. Patients with acute or chronic infectious disease including hepatitis, tuberculosis, human immunodeficiency virus (HIV), and chronic urinary tract infections.
• •4. Patients with liver cirrhosis, as assessed by the Investigator.
• •5. Patients with a diagnosis of type 1 or type 2 diabetes mellitus which is poorly controlled.
• •6. Patients with history of unstable angina, class III or IV congestive heart failure, and/or clinically significant arrhythmia, as judged by the Investigator;
• •7. Patients with unacceptable blood pressure control defined as a blood pressure consistently above national guidelines for proteinuric renal disease, as assessed by the Investigator
• •8. Patients with diagnosed malignancy within the past 5 years.